Toronto Research Chemicals
Ken joined LGC as Executive Vice President and General Manager, LGC Standards in September 2022. Prior to joining LGC, Ken co-founded Fortis Life Sciences in 2020 where he served as Chief Operating Officer. Before Fortis, he held several senior executive roles at MilliporeSigma over the course of 10 years, most recently as the Vice President and Head of the Lab and Specialty Chemicals Business Unit. Earlier in his career, Ken worked as a management consultant for McKinsey and Company, and as a postdoctoral fellow at the Novartis Institute for Biomedical Research. Ken graduated with a PhD in Neuroscience from Yale University, and a BS with Honors in Chemistry from Stanford University.
This person is not in any teams
This person is not in any offices
Toronto Research Chemicals
1 followers
Toronto Research Chemicals Inc. is a manufacturer research chemicals . Our catalog lists over 65,000 compounds, including - amino acids and derivatives, aromatics, carbohydrates, detergents, fluorescent labels and indicators, glycerols and fatty acids, hydantoins inhibitors, methane thiosulfonates, mutagens, neurochemicals, nitric oxide synthase reagents, oligosaccharides, protein kinase C activators and inhibitors, tyrosine kinase inhibitors, drug metabolites and forensic products. We also specialize in custom synthesis and contract research of organic chemicals / biochemicals. TRC also can manufacture labelled compounds using Carbon 14, Tritium, Carbon 13, and Nitrogen 15 and deuterium. Toronto Research has also expanded its capabilities and product line through the acquisition of Synfine Research, a wholly owned subsidiary with ISO 9001 certification.